Aminoverse and Prozomix collaboration

Screen 1000s of enzymes, refine the best, and secure scalable supply: Aminoverse and Prozomix collaboration

Nuth, Netherlands / Haltwhistle, UK, 10.09.2025 - Aminoverse, a leader in enzyme discovery and engineering, and Prozomix, a pioneer in enzyme diversity and biocatalyst supply, today announced a strategic collaboration designed to accelerate innovation in industrial biocatalysis.

Under the new agreement, Aminoverse will gain access to Prozomix's complete portfolio spanning >6000 diverse native biocatalysts for use in its R&D service projects. This enables Aminoverse to integrate the vast biocatalytic diversity curated by Prozomix into its advanced screening and engineering workflows. At the same time, Prozomix benefits from significantly broadened market access, as Aminoverse will bring these enzymes into new client projects worldwide.

"This collaboration brings together two highly complementary strengths," said David Schönauer, CEO of Aminoverse. "With Prozomix's unparalleled off-the-shelf enzyme diversity and our technology platform for screening, design, and engineering, we can offer clients powerful new opportunities to discover and optimise enzymes tailored to their applications."

Aminoverse combines AI-driven discovery with state-of-the-art wet-lab platforms, enabling the rapid evaluation and engineering of enzymes for applications across pharmaceuticals, fine chemicals, and sustainable materials. With access to Prozomix's enzyme collection, Aminoverse can now accelerate screening projects and directly advance promising enzymes into tailored optimisation and process development.

Prozomix has established itself as a leading provider of speciality enzymes, offering one of the most diverse biocatalyst collections available. With Pilot and Production facilities offering several cubic meters of flexible fermentation capacity, Prozomix can also rapidly supply bulk amounts of improved enzymes, ensuring reliable and scalable delivery from discovery through to commercial manufacturing. By collaborating with Aminoverse, Prozomix will extend the reach of its portfolio to new applications and enhance its impact on industrial biotechnology, especially with engineered enzymes.

"This partnership ensures that the full potential of our Biocatalysis Enzyme Toolkit is realised," said Simon Charnock, CEO of Prozomix. "Through Aminoverse's expertise in screening and engineering, more customers will be able to identify and adapt the best enzymes for their needs, while our production capacity ensures they can access these solutions from lab to commercial scale seamlessly and without usual risk."

The collaboration represents a significant step towards bridging enzyme diversity with enzyme innovation, creating new pathways for sustainable and efficient biocatalytic processes.

Aminoverse B.V.
Daelderweg 9
6361 HK Nuth
Netherlands

info@aminoverse.com

About Aminoverse
Aminoverse is all about enzymes. The profitable company enables chemistry players across diverse industries to onboard more cost-efficient and sustainable manufacturing by delivering the right enzyme and process. With its proprietary symbiosis of wet lab work, state-of-the-art in silico modelling, and data-driven AI, the Dutch start-up removes bottlenecks in enzyme science like long lead times or uncertain research outcomes.
📧 info@aminoverse.com
🌐 www.aminoverse.com

About Prozomix
Prozomix is a UK-based biotechnology company with long history offering one of the largest collections of specialty enzymes worldwide. With a focus on enzyme diversity and supply, including as CMO, Prozomix provides biocatalysts that power research, development, and production across multiple industries globally.
📧 info@prozomix.com
🌐 www.prozomix.com

This release was published on openPR.